Goldman Sachs’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,062
| Closed | -$5K | – | 5501 |
|
|
2022
Q2 | $5K | Buy |
+1,062
| New | +$5K | ﹤0.01% | 5583 |
|
|
2022
Q1 | – | Sell |
-1,473
| Closed | -$11K | – | 5762 |
|
|
2021
Q4 | $11K | Sell |
1,473
-11,690
| -89% | -$87.3K | ﹤0.01% | 5496 |
|
|
2021
Q3 | $166K | Buy |
13,163
+1,649
| +14% | +$20.8K | ﹤0.01% | 4926 |
|
|
2021
Q2 | $173K | Buy |
11,514
+4,411
| +62% | +$66.3K | ﹤0.01% | 4966 |
|
|
2021
Q1 | $118K | Buy |
7,103
+4,414
| +164% | +$73.3K | ﹤0.01% | 4986 |
|
|
2020
Q4 | $44K | Sell |
2,689
-4,760
| -64% | -$77.9K | ﹤0.01% | 4572 |
|
|
2020
Q3 | $83K | Buy |
+7,449
| New | +$83K | ﹤0.01% | 4258 |
|
|
2018
Q3 | – | Sell |
-3,459
| Closed | -$152K | – | 4123 |
|
|
2018
Q2 | $152K | Buy |
+3,459
| New | +$152K | ﹤0.01% | 3941 |
|